Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study

Table 2 Clinical and pathological characteristics in control and adjuvant TACE groups patients with risk factors for re-sidual tumor

Characteristics	Control	Adjuvant TACE group	P value
	(n = 190)	(n = 108)
Gender
Female	33	12	0.147
Male	157	96
Age (mean ± SD)	51.50 ± 11.72	49.63 ± 10.07	0.105
HBsAg
Positive	47	27	0.588
Negative	143	81
Cirrhosis
Absent	41	24	0.563
Mild	69	45
Severe	80	39
Child-pugh Class
A	187	106	0.860
B	3	2
AFP (mean ± SD, μg/L)	501.39 ± 807.14	518.25 ± 707.99	0.856
TNM classification
II	113	66	0.926
IIIA	55	31
IVA	22	11